Immunomodulatory assays to study structure-activity relationships of thalidomide (Q73097134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Immunomodulatory assays to study structure-activity relationships of thalidomide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

E J Shannon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M J Morales

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Sandoval

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

203-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

(S)-form of alpha-methyl-N(alpha)-phthalimidoglutarimide, but not its (R)-form, enhanced phorbol ester-induced tumor necrosis factor-alpha production by human leukemia cell HL-60: implication of optical resolution of thalidomidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Enhancement of 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor alpha production by phenethylphthalimide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Benzylphthalimides and phenethylphthalimides with thalidomide-like activity on the production of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Enhancement of phorbol ester-induced production of tumor necrosis factor-alpha by 2,6-dimethylphenylphthalimide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2896%2900149-X

7 January 2021

10.1016/S0162-3109(96)00149-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9043933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference